TrialProceedings of the National Academy of Sciences of the United States of America2005

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.

Daniel P Webster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.